Shingrix in 2017 received US FDA approval to prevent shingles in adults aged 50 and older. Since 2021, it has been approved for use in immunocompromised patients aged 18 and up. GSK estimates around ...

LONDON - GSK plc (LSE/NYSE: LON:GSK) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational drug GSK'227, aimed at treating adults with ...

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer.

London stocks were set to nudge lower at the open on Friday following a downbeat session in Asia and as investors eyed the ...

London open The FTSE 100 is expected to open 14 points lower on Friday, having closed up 0.83% on Thursday at 8,319.69.

GSK plc announced an update regarding its total voting rights and capital for shareholders, as required by the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. As of December ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

A high-profile team of architects, landscape designers, and consultants has been appointed to progress a masterplan for the ...

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...

dRMM and Studio Egret West is drawing up a major redevelopment plan for GlaxoSmithKline’s (GSK’s) former west London HQ The project team has been assembled by Hadley Property Group to redevelop the ...